logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

Failed appeals rise again

19 January 2015

Significantly more admissions appeals fail than succeed. For places in September 2014, only 16% of primary appeals succeeded and in secondary schools the success rate was just under 24%. Both figures are down on last year. With 44,015 appeals lodged over all, we really must question the effectiveness of the current appeal system.

In her annual report, chief schools adjudicator Elizabeth Passmore states that a number of local authorities would welcome a 'paper panel' for reception year places. This is a step in the right direction, but why limit it to reception places only?

Given the costs and resources involved in planning, preparing for and hearing appeals, there is no reason why secondary appeals could not also be considered on the papers in the first instance. The time and cost saving would be significant and allow local authorities and academies to channel the money back into educating pupils.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up